The WHO and Gates Foundation using African children as guinea-pigs for a harmful Malaria vaccine.

I first heard of children getting maimed after receiving the malaria vaccine (RTS, S) known by its brand name Mosquirix, during its trial pilot in Western Kenya. Children suffered febrile seizures and meningitis as reported by local media and the Ministry of Health Kenya could not confirm exactly how many children suffered life-threatening side effects or died after receiving this vaccine. Monitoring and following up with vaccinated children is hard in Africa due to the lack of digital systems recording vaccine adverse effects, or health and mortality statistics. Also, Africans are not aware or advised of the detrimental side effects of this vaccine, so they wouldn’t know how or where to report their children’s vaccine injuries.

So how did this risky, low-efficacy malaria vaccine receive an approval and recommendation by the World Health Organization (WHO)? Yet the European Medicines Agency that gave it a positive opinion for use ‘outside the European Union’, highlighted the grave side effects of this vaccine?

It is good to note an existing conflict of interest, where the World Health Organization is funded by the Bill Melinda Gates Foundation (BMGF).  This Mosquirix vaccine was developed by GlaxoSmithKline and the BMGF also provided catalytic funding for late stage development of this vaccine according to WHO. Other organizations involved in accelerating the Vaccines development include PATH, Gavi the Vaccine Alliance and Global Fund that all receive funding from BMGF.  Could that be the reason for the ‘rushed consensus’ to administer the vaccine and offer it to African children?

Low Vaccine Efficacy.

The Mosquirix vaccine is a four-dose regimen that is only 30% effective at preventing severe malaria, for less than four years due to its waning efficacy. Ironically, this falls way below the WHO 75% threshold. 

So why did the WHO approve and recommend this vaccine whose risks outweigh its benefits? Gavi, the Vaccine Alliance started rolling out this vaccine to African countries. 

On March 6th 2023, the Ministry of Health Kenya in partnership with PATH and Gavi, the Vaccine Alliance rolled out this vaccine for mass use in Kenya offering it to children, without disclosing the life-threatening side effects and obtaining informed consent from parents. They touted this vaccine as ‘life-saving’, a ‘game-changer’ being the first Malaria vaccine in the world, yet it is ineffective as a stand-alone regimen, and requires other Malaria intervention measures to succeed, due to its low-efficacy. It is good to note that there were already better and more effective antimalarial drugs in Africa, so this dangerous low-efficacy vaccine was not entirely urgently needed.

Adverse (Side) Effects.

The side effects of these vaccines ironically include cerebral malaria, for a vaccine that is trying to ‘prevent malaria’. Other deadly adverse effects are the risk of febrile seizures and convulsions and the risk of developing meningitis increased ten times after receiving the vaccine. So is this vaccine worth the risk, given its 30% likelihood of preventing severe malaria?

The European Medicines Agency has highlighted the following side effects for the low efficacy Mosquirix vaccine include but are not limited to

Adverse effects of Mosquirix: Image credit: European Medicines Agency

The 'Ending Malaria in Africa' Scam

Remember when Bill Gates released a swarm of mosquitoes onto an unsuspecting audience? This crass presentation was to draw attention to the malaria problem in developing countries. It also turned out that he had been funding the release of genetically modified mosquitoes into the wild.

 Target Malaria a research consortium funded by BMGF released genetically engineered mosquitoes into the wild in Africa, in an effort to reduce the population of malaria causing mosquitoes through gene drives. Coincidentally, a new vector ‘super mosquito’ has emerged known as Anopheles stephensi that according to Kenya Medical Research Institute (also funded by BMGF) could ‘reverse the gains in the fight against malaria’.  This vector is insecticide resistant and thrives in different environments and climatic conditions, and spreads severe deadly malaria. This could be the reason why all these organizations are drumming up the support for this harmful vaccine. 

The World Health Organization certified Sri Lanka ‘Malaria-free’ in 2016.  The Maldives was also able to eliminate Malaria. That was way before the need for a harmful malaria vaccine. So if other countries have been able to successfully eradicate Malaria, why is WHO and the Gates Foundation not following these proven strategies in ‘fighting’ malaria in Africa? Why are they pushing a dangerous vaccine to African children? It is evidently clear that the WHO and the Gates foundation are using this vaccine to pursue their own selfish interests in Africa. One of our recent articles highlighted the controversial efforts in ‘fighting malaria’.